N

National Allergy and Asthma Research LLC | North Charleston, SC

Research site

(Unclaimed)

Location

7555 Northside Drive, North Charleston, South Carolina, United States of America

Site insights

Top conditions

Top treatments

Dupilumab

OPN-375

Bradanicline

EVO756

Rocatinlimab

CDX-0159

BMX-010

Symbicort®

EP262

NOC-110

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 22 total trials

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis (Adoring)

The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 2...

Enrolling

Atopic Dermatitis

Drug: Vehicle Cream

Drug: Tapinarof cream, 1%

Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)

This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe chronic spontaneous urticaria (CSU).

Enrolling

Chronic Spontaneous Urticaria

Drug: EVO756

Drug: Placebo control

Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough (ASPIRE)

This is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalatio...

Enrolling

Refractory or Unexplained Chronic Cough

Drug: NOC-110

Other: Placebo